TYLER NEWMAN: Open Payments
NPI 1205227709 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 17 payments from 11 companies in 2025. Trend: 2023 $632 · 2024 $293 · 2025 $502
Food & beverage: $350Education: $152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $94 |
| UCB, Inc. | 2 | $63 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| LEO Pharma Inc. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: TREMFYA, SPEVIGO, Bimzelx, Zoryve, LIBTAYO, Cabtreo, ANZUPGO, NEMLUVIO.
Industry payments across UT — which companies pay providers there.
